Doxorubicin Hydrochloride Liposome
- Product NDC
- 25021-263
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxorubicin Hydrochloride
- Dosage form
- INJECTION, SUSPENSION, LIPOSOMAL
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA219881
- Marketing category
- ANDA
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 25021-263-10 | 1 VIAL in 1 CARTON (25021-263-10) / 10 mL in 1 VIAL | 2026-03-01 | | No | Historical |
| 25021-263-25 | 1 VIAL in 1 CARTON (25021-263-25) / 25 mL in 1 VIAL | 2026-03-01 | | No | Historical |